There’s a saying that your can choose between access, quality, and low cost but you can only choose two. The US system has chosen quality and access at the expense of cost.
Other countries benefit largely from the US healthcare R&D machine. The US funds over 40% of the world medical R&D. While other countries put price controls on their medicine, this arrangement won’t work with the current system if the US does the same. To a certain extent, US high prices partly subsidized the rest of the world.
Other countries benefit largely from the US healthcare R&D machine. The US funds over 40% of the world medical R&D. While other countries put price controls on their medicine, this arrangement won’t work with the current system if the US does the same. To a certain extent, US high prices partly subsidized the rest of the world.